Ad Alert

Green Roads Health

FDA reminds marijuana marketers that outing unproven treatment claims remains high on its list.

As more states move to legalize medical marijuana — at 29, there are now more states that have than haven’t — some companies are taking the proliferation of state-sanctioned pot for medicinal purposes as a cue to market their own marijuana-based products to treat or cure a number of serious diseases, including cancer.

These companies include Green Roads Health, which claimed on its website that cannabidiol or CBD in its various drops, capsules, syrups, and edibles (weed lollipops, anyone?) helps patients suffering from Alzheimer’s disease, arthritis, autism, bipolar disorder, and “various types of cancer.” Unlike tetrahydrocannabinol or THC, CBD is the compound in marijuana that does not make people high. On its website Green Roads Health touted CBD as having “properties that inhibit cell division and growth in certain types of cancer, not allowing the tumor to grow.”

Yet the FDA has not approved any product containing or derived from botanical marijuana for the treatment of any health condition. That puts the company’s health claims square in the category of Only FDA-approved drugs can be marketed as having the ability to diagnose, cure, treat, prevent or mitigate a disease., as the FDA recently informed the Florida-based firm in a warning letter dated Oct. 31.

“Substances that contain components of marijuana will be treated like any other products that make unproven claims to shrink cancer tumors,” said FDA Commissioner Scott Gottlieb in a statement. “We don’t let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer and we’re not going to look the other way on enforcing these principles when it comes to marijuana-containing products.”

At the same time, the FDA is cognizant of early research on the potential promise medical marijuana holds out for sufferers of serious conditions such as epilepsy, anxiety and schizophrenia. And while the agency has yet to green-light a plant-based marijuana product, it has approved medications containing synthetic THC for the treatment of anorexia associated with weight loss in AIDS patients and for chemotherapy-related nausea and vomiting.

“We recognize that there’s interest in developing therapies from marijuana and its components, but the safest way for this to occur is through the drug approval process — not through unsubstantiated claims made on a website,” Gottlieb said.

As of Nov. 6, Green Roads Health’s website was down. But the company wasn’t the only online purveyor of miracle marijuana-based products that received a warning letter from the FDA. Read about the others here: That’s Natural, Natural Alchemist, Charlotte’s Web.

Find more of our coverage on marijuana here.

Our Ad Alerts are not just about false and deceptive marketing issues, but may also be about ads that, although not necessarily deceptive, should be viewed with caution. Ad Alerts can also be about single issues and may not include a comprehensive list of all marketing issues relating to the brand discussed.

You Might Be Interested In